Adaptive Biotechnologies Corp (ADPT)
$25.80-$0.64 (-2.42%) Today
Katey Einterz Owen - Director
Robert Hershberg - DirectorRobert Hershberg - Director
Peter M. Neupert - DirectorAdaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.
https://www.adaptivebiotech.comSEC filings for ADPT on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 31 | 2,239,786 | $50.57M |
| Option exercise | 52 | 2,564,234 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
73 Form 4 filings on record, the earliest from Oct 10, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $7.27 | $107K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 2,738 | $12.49 | $34K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 16,322 | $13.48 | $220K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $7.27 | $107K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $12.63 | $241K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $7.27 | $107K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $13.45 | $256K | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $7.27 | $107K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $13.70 | $261K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $7.27 | $107K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $14.27 | $272K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $7.27 | $107K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $14.12 | $269K | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $6.55 | $96K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $13.18 | $251K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 3,939 | $6.55 | $26K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 10,783 | $7.27 | $78K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $13.37 | $255K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $7.27 | $107K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $13.83 | $264K | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 3,939 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 10,783 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $6.55 | $96K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $13.41 | $256K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $6.55 | $96K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $13.40 | $255K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $6.55 | $96K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $13.18 | $251K | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 122,523 | $13.17 | $1.61M | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $6.55 | $96K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $14.08 | $268K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $6.55 | $96K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 13,660 | $12.63 | $173K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 5,400 | $13.43 | $73K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $6.55 | $96K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $12.96 | $247K | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
 Michelle Renee Griffin - Director | Open-market sale | Common Stock | 15,394 | $13.91 | $214K | |
| Francis Lo - Officer | Open-market sale | Common Stock | 30,593 | $14.08 | $431K | |
| Susan Bobulsky - Officer | Open-market sale | Common Stock | 41,338 | $13.17 | $544K | |
| Sharon Benzeno - Officer | Open-market sale | Common Stock | 63,103 | $13.17 | $831K | |
| Kyle Piskel - Officer | Open-market sale | Common Stock | 18,672 | $13.17 | $246K | |
| Harlan S. Robins - Officer | Open-market sale | Common Stock | 140,666 | $13.17 | $1.85M | |
| Harlan S. Robins - Officer | Open-market sale | Common Stock | 329,600 | $13.17 | $4.34M | |
| Chad M. Robins - Officer | Open-market sale | Common Stock | 140,567 | $13.17 | $1.85M | |
| Chad M. Robins - Officer | Open-market sale | Common Stock | 329,600 | $13.17 | $4.34M | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 30,941 | $14.79 | $458K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $6.55 | $96K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 400 | $12.14 | $5K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,460 | $14.68 | $286K | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 11,881 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 11,881 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 400 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $6.55 | $96K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 11,881 | $12.14 | $144K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 30,941 | $15.14 | $468K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $6.55 | $96K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 11,881 | $12.14 | $144K | |
| Francis Lo - Officer | Open-market sale | Common Stock | 38,074 | $15.09 | $575K | |
| Peter M. Neupert - Director | Grant or award | Common Stock | 15,625 | $0.00 | - | |
| Robert Hershberg - Director | Grant or award | Common Stock | 15,625 | $0.00 | - | |
| Francis Lo - Officer | Grant or award | Common Stock | 44,063 | $0.00 | - | |
| Susan Bobulsky - Officer | Grant or award | Common Stock | 59,375 | $0.00 | - | |
| Susan Bobulsky - Officer | Grant or award | Common Stock | 62,500 | $0.00 | - | |
| Sharon Benzeno - Officer | Grant or award | Common Stock | 39,063 | $0.00 | - | |
| Julie Rubinstein - Officer | Grant or award | Common Stock | 81,250 | $0.00 | - | |
| Harlan S. Robins - Officer | Grant or award | Common Stock | 127,813 | $0.00 | - | |
| Harlan S. Robins - Officer | Grant or award | Common Stock | 709,220 | $0.00 | - | |
| Kyle Piskel - Officer | Grant or award | Common Stock | 61,875 | $0.00 | - | |
| Katey Einterz Owen - Director | Grant or award | Common Stock | 15,625 | $0.00 | - | |
| Michelle Renee Griffin - Director | Grant or award | Common Stock | 15,625 | $0.00 | - | |
| Chad M. Robins - Officer | Grant or award | Common Stock | 127,813 | $0.00 | - | |
| Chad M. Robins - Officer | Grant or award | Common Stock | 709,220 | $0.00 | - | |
| Michelle Renee Griffin - Director | Option exercise | Common Stock | 48,044 | $3.99 | $192K | |
| Michelle Renee Griffin - Director | Open-market sale | Common Stock | 48,044 | $15.30 | $735K | |
| Michelle Renee Griffin - Director | Option exercise | Stock Option (right to buy) | 48,044 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $6.55 | $96K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 11,881 | $12.14 | $144K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 24,423 | $15.49 | $378K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 6,518 | $16.33 | $106K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $6.55 | $96K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 11,881 | $12.14 | $144K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 30,941 | $16.60 | $514K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $6.55 | $96K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 11,881 | $12.14 | $144K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 30,941 | $16.00 | $495K | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 11,881 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 11,881 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 11,881 | $0.00 | - | |
| Harlan S. Robins - Officer | Open-market sale | Common Stock | 10,000 | $15.72 | $157K | |
| Harlan S. Robins - Officer | Open-market sale | Common Stock | 14,233 | $16.52 | $235K | |
| Chad M. Robins - Officer | Open-market sale | Common Stock | 2,380 | $16.15 | $38K | |
| Chad M. Robins - Officer | Open-market sale | Common Stock | 182,891 | $15.99 | $2.92M | |
| Chad M. Robins - Officer | Open-market sale | Common Stock | 289,024 | $15.82 | $4.57M | |
| Chad M. Robins - Officer | Open-market sale | Common Stock | 50,703 | $15.49 | $785K | |
| Kyle Piskel - Officer | Option exercise | Common Stock | 2,145 | $12.14 | $26K | |
| Kyle Piskel - Officer | Open-market sale | Common Stock | 2,145 | $18.46 | $40K | |
| Kyle Piskel - Officer | Option exercise | Stock Option (right to buy) | 2,145 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| KATHERINE E OWEN | Director | 9,615 | $250K | View on EDGAR | |
| Harlan Robins | Former Officer | 402,160 | $10.23M | View on EDGAR | |
| Harlan Robins | Former Officer | 215,632 | $5.50M | View on EDGAR |
Adaptive Biotechnologies Corp (ADPT) had 19 insider filings in the last 90 days, with the most recent on 2026-08-28. The full record for ADPT runs to 73 Form 4 filings, the earliest from 2024-10-10. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of ADPT were filed in the last 90 days.
31 insider sales of ADPT were filed in the last 90 days, totaling $50.57M.
This page tracks ADPT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ADPT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
